| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 126 | 136 | 102 | 105 | 118 | 119 | 81 | 100 | 114 | 131 | 150 | 173 | 164 | 176 | 123 | 61 | 65 | 160 | 151 | 151 | 136 | 167 | 163 | 248 | 166 | 198 | 176 | 250 | 197 |
| Expenses | 101 | 110 | 76 | 88 | 94 | 96 | 60 | 82 | 91 | 107 | 114 | 130 | 119 | 128 | 94 | 65 | 65 | 146 | 130 | 126 | 109 | 139 | 133 | 212 | 131 | 165 | 140 | 207 | 157 |
| EBITDA | 24 | 27 | 26 | 16 | 24 | 23 | 21 | 18 | 22 | 25 | 35 | 42 | 46 | 48 | 29 | -4 | 0 | 14 | 21 | 25 | 27 | 29 | 31 | 35 | 35 | 33 | 35 | 42 | 40 |
| Operating Profit % | 19 % | 19 % | 25 % | 15 % | 20 % | 19 % | 25 % | 15 % | 19 % | 18 % | 23 % | 24 % | 27 % | 27 % | 22 % | -7 % | -1 % | 9 % | 12 % | 16 % | 19 % | 17 % | 18 % | 14 % | 20 % | 16 % | 19 % | 16 % | 20 % |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 10 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 5 | 5 | 5 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 4 | 5 | 6 |
| Profit Before Tax | 16 | 19 | 19 | 8 | 15 | 14 | 13 | 9 | 14 | 16 | 27 | 34 | 33 | 35 | 16 | -16 | -13 | 1 | 7 | 11 | 13 | 15 | 17 | 22 | 22 | 20 | 22 | 29 | 24 |
| Tax | 9 | 9 | 9 | -5 | 8 | 5 | 5 | 2 | 7 | 5 | 5 | 11 | 9 | 12 | 7 | -23 | 0 | 3 | 3 | 4 | 3 | 3 | 5 | 5 | 5 | 5 | 4 | 8 | 4 |
| Net Profit | 7 | 10 | 9 | 13 | 8 | 10 | 8 | 6 | 7 | 11 | 21 | 23 | 24 | 23 | 9 | 6 | -13 | -2 | 4 | 6 | 9 | 12 | 12 | 17 | 17 | 14 | 18 | 20 | 21 |
| EPS in ₹ | 0.85 | 1.19 | 1.11 | 1.57 | 0.92 | 1.17 | 0.90 | 0.76 | 0.83 | 1.30 | 2.53 | 2.73 | 2.78 | 2.72 | 1.07 | 0.73 | -1.51 | -0.24 | 0.44 | 0.73 | 1.10 | 1.39 | 1.36 | 2.04 | 1.95 | 1.67 | 2.15 | 2.40 | 2.31 |
SMS Pharmaceuticals
SMS Pharmaceuticals
289.25
+4.60
(1.62%)
There are new updates from the company19 hours ago
View
Key Fundamentals
Market Cap
2,523.50 Cr
EPS
8.16
PE Ratio
36.98
Dividend Yield
0.13 %
Industry
Healthcare 52 Week High
315.00
52 Week Low
176.05
PB Ratio
3.94
Debt to Equity
0.50
Sector
Pharmaceuticals Actual
Company News
View All News
SMS Pharmaceuticals Limited has received trading approval from BSE and NSE for 50,00,000 equity shares of Re. 1 each issued at a premium of Rs. 126 per share. The shares were allotted to promoters on a preferential basis pursuant to conversion of warrants. The equity shares are listed and admitted for trading on both exchanges with effect from November 7, 2025, bearing distinctive numbers from 88652031 to 93652030. The shares have a lock-in period until October 30, 2027.
Vistra ITCL (India) Limited, acting as debenture trustee, released 1,06,20,000 equity shares of SMS Pharmaceuticals Limited from pledge on November 3, 2025. Following this release, Vistra's encumbered shareholding in SMS Pharmaceuticals decreased from 23.58% to 12.24% of the total share capital. The company's total equity share capital remains at 9,36,52,030 shares with a face value of Rs. 1 each. Vistra filed this disclosure under SEBI takeover regulations as a precautionary measure, noting that the primary compliance responsibility lies with the lender and debenture holder rather than the trustee.
SMS Pharmaceuticals Promoter Releases Pledge on 1.06 Crore Equity Shares3 days ago
HimaBindu Potluri, a promoter of SMS Pharmaceuticals Limited, released pledge on 1,06,20,000 equity shares on November 3, 2025. The pledge release was related to security created against debentures issued by VKT Pharma Private Limited, an associate company. Following this release, Potluri's total shareholding remains at 1,50,08,840 shares (16.03% of total share capital), but pledged shares reduced from 1,36,20,000 to 30,00,000 shares. The company's total equity share capital stands at 9,36,52,030 equity shares of Rs. 1 each. The shares are listed on BSE Limited and National Stock Exchange of India Limited.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,691.40 | #1 4,04,503.90 | 38.74 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 55.98 | |
6,656.50 | 1,82,735.30 | 71.11 | 9,712.00 | 18.67 | 2,191 | 35.10 | 58.39 | |
1,505.70 | 1,21,284.30 | 22.36 | 28,409.50 | 7.12 | 5,291 | 3.71 | 40.84 | |
3,580.00 | 1,21,163.50 | 60.51 | 11,539.40 | 6.99 | 1,911 | 30.46 | 50.54 | |
1,205.40 | 1,00,587.70 | #1 17.53 | 33,741.20 | 16.73 | 5,725 | -0.38 | 37.06 | |
2,261.80 | 95,310.10 | 52.66 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 25.15 | |
944.10 | 94,998.60 | 18.88 | 23,511.00 | 18.55 | 4,615 | 34.60 | 33.87 | |
1,971.80 | 89,318.30 | 20.71 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 53.33 | |
5,668.50 | 67,476.50 | 29.08 | 13,458.30 | 3.70 | 2,216 | 21.39 | 63.91 | |
1,123.80 | 66,246.20 | 19.24 | 32,345.60 | 9.43 | 3,484 | 3.81 | 53.78 |
Growth Rate
Revenue Growth
35.43 %
Net Income Growth
1,161.54 %
Cash Flow Change
63.03 %
ROE
991.67 %
ROCE
192.43 %
EBITDA Margin (Avg.)
50.49 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 656 | 493 | 503 | 559 | 608 | 812 | 860 | 880 | 1,034 | 1,153 |
| Fixed Assets | 370 | 291 | 279 | 281 | 281 | 457 | 438 | 412 | 437 | 533 |
| Current Assets | 248 | 157 | 169 | 208 | 219 | 309 | 377 | 411 | 534 | 555 |
| Capital Work in Progress | 13 | 8 | 8 | 18 | 42 | 7 | 11 | 33 | 30 | 35 |
| Investments | 0 | 29 | 28 | 27 | 26 | 27 | 22 | 11 | 11 | 12 |
| Other Assets | 272 | 166 | 187 | 232 | 260 | 321 | 389 | 424 | 556 | 573 |
| Total Liabilities | 656 | 493 | 503 | 559 | 608 | 812 | 860 | 880 | 1,034 | 1,153 |
| Current Liabilities | 200 | 147 | 122 | 143 | 145 | 195 | 197 | 255 | 332 | 324 |
| Non Current Liabilities | 162 | 91 | 97 | 94 | 115 | 206 | 193 | 164 | 166 | 189 |
| Total Equity | 294 | 255 | 285 | 322 | 348 | 411 | 470 | 461 | 536 | 640 |
| Reserve & Surplus | 285 | 246 | 276 | 314 | 340 | 402 | 462 | 452 | 499 | 615 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -9 | 1 | 0 | 2 | -5 | 31 | 6 | -39 | 29 | 5 |
| Investing Activities | -97 | -39 | -17 | -35 | -43 | -152 | -27 | -30 | -52 | -123 |
| Operating Activities | 61 | 74 | 32 | 50 | 40 | 90 | 45 | 23 | 50 | 82 |
| Financing Activities | 27 | -33 | -15 | -13 | -2 | 92 | -12 | -32 | 31 | 47 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 67.29 % | 67.29 % | 67.29 % | 67.29 % | 67.29 % | 64.17 % | 64.17 % | 64.17 % | 64.29 % | 64.32 % | 64.32 % | 64.32 % | 64.67 % | 64.67 % | 64.67 % | 64.67 % | 66.26 % | 66.26 % | 68.07 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.60 % | 0.59 % | 0.17 % | 0.17 % | 0.52 % | 0.31 % | 0.08 % | 0.03 % | 0.28 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.98 % | 2.13 % | 2.55 % | 2.55 % | 2.43 % | 3.03 % | 2.88 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 26.92 % | 26.87 % | 26.23 % | 26.72 % | 26.38 % | 29.65 % | 28.84 % | 28.82 % | 29.00 % | 29.04 % | 29.08 % | 29.22 % | 27.93 % | 27.81 % | 27.04 % | 27.38 % | 26.35 % | 25.89 % | 24.02 % |
| Others | 5.79 % | 5.84 % | 6.47 % | 5.99 % | 6.33 % | 6.18 % | 6.98 % | 7.00 % | 6.70 % | 6.64 % | 6.01 % | 5.88 % | 5.25 % | 5.22 % | 5.23 % | 5.09 % | 4.87 % | 4.78 % | 4.76 % |
| No of Share Holders | 19,878 | 25,601 | 24,608 | 24,959 | 27,516 | 26,638 | 26,491 | 26,526 | 25,537 | 24,653 | 25,246 | 25,341 | 30,140 | 31,780 | 33,136 | 34,973 | 35,332 | 33,652 | 34,157 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.2 | 0.25 | 0.25 | 0.25 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 |
| Dividend Yield (%) | 0.00 | 0.27 | 0.4 | 0.93 | 0.2 | 0.32 | 0.53 | 0.17 | 0.19 | 0.14 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Nov 2025 |  Quarterly Result Announcement | NA | 08 Nov 2025 | 286.20 | 288.80 |
| 24 Sept 2021 |  Dividend | ₹ 0.30 /share | 22 Sept 2021 | 167.60 | 157.70 |
| 23 Sept 2022 | Dividend | ₹ 0.30 /share | 22 Sept 2022 | 84.35 | 89.80 |
| 22 Sept 2023 | Dividend | ₹ 0.30 /share | 22 Sept 2023 | 84.40 | 121.50 |
| 06 Mar 2024 |  Extraordinary General Meeting | NA | 06 Mar 2024 | 146.45 | 181.90 |
| 23 Sept 2024 | Dividend | ₹ 0.40 /share | 23 Sept 2024 | 209.90 | 368.65 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 312.55 | 351.20 |
| 08 Nov 2024 | Quarterly Result Announcement | NA | 08 Nov 2024 | 294.60 | 305.90 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 205.15 | 200.02 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 262.50 | 270.37 |
| 09 Aug 2025 | Quarterly Result Announcement | NA | 09 Aug 2025 | 228.91 | 223.95 |
| 22 Sept 2025 | Dividend | ₹ 0.40 /share | 22 Sept 2025 | 270.37 | 292.50 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 223.95 | 251.68 |
Announcements
Intimation Of Receipt Of Trading Approval From Stock Exchanges
19 hours ago
19 hours agoDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 20112 days ago
2 days agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 20112 days ago
2 days agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 20112 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
2 days agoReport On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window2 days ago
2 days agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 20113 days ago
3 days agoBoard Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30Th September 20255 days ago
5 days agoIntimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 16, 2025
Oct 16, 2025Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special WindowOct 10, 2025
Oct 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 29, 2025
Sep 29, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 13, 2025
Sep 13, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 13, 2025
Sep 13, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 13, 2025
Sep 13, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 13, 2025
Sep 13, 2025Clarification On Volume/Price MovementSep 12, 2025
Sep 12, 2025Clarification sought from SMS Pharmaceuticals LtdSep 12, 2025
Sep 12, 2025Conversion Of 5000000 Warrants Into Equity SharesSep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Conversion of SecuritiesSep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 08, 2025
Sep 08, 2025Dispatch Of Letter With Web-Link To Annual ReportSep 06, 2025
Sep 06, 2025Business Responsibility and Sustainability Reporting (BRSR)Sep 06, 2025
Sep 06, 2025Reg. 34 (1) Annual Report.Sep 06, 2025
Sep 06, 2025Notice Of 37Th Annual General Meeting And Annual Report For The FY 2024-25Sep 06, 2025
Sep 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 26, 2025
Aug 26, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 25, 2025
Aug 25, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Aug 22, 2025
Aug 22, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Aug 22, 2025
Aug 22, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 22, 2025
Aug 22, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 22, 2025
Aug 22, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Aug 22, 2025
Aug 22, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Aug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2025
Aug 11, 2025Investor Presentation On Financial ResultsAug 10, 2025
Aug 10, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 10, 2025
Aug 10, 2025Results For The Quarter Ended June 30 2025Aug 09, 2025
Aug 09, 2025Record Date For The Purpose Of Determining The Members Eligible To Receive Dividend For The Financial Year 2024-25Aug 09, 2025
Aug 09, 2025Statement Of Deviation Or Variation For The Quarter Ended June 30 2025Aug 09, 2025
Aug 09, 2025Board Meeting Outcome for Outcome Of Board Meeting And Financial ResultsAug 09, 2025
Aug 09, 2025Board Meeting Intimation for Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended On 30Th June 2025Aug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 10, 2025
Jul 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Intimation Under Regulation 30 Of SEBI LODR Regulations 2015 - Reminder Letter For Transfer Of Shares To Investor Education And Protection Fund (IEPF)Jul 08, 2025
Jul 08, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Quant Healthcare Fund Direct - Growth | 6.53% | 43932 | 1.12% | 1.39% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.00% | -395 | -0.05% | -0.05% | |
| Quant Small Cap Fund Direct Plan-Growth | 0.17% | 0 | 0.02% | 0.02% |
Technical Indicators
RSI(14)
Neutral 56.25
ATR(14)
Volatile 10.39
STOCH(9,6)
Neutral 23.95
STOCH RSI(14)
Neutral 20.01
MACD(12,26)
Bearish -1.42
ADX(14)
Strong Trend 31.14
UO(9)
Bearish 44.65
ROC(12)
Downtrend And Accelerating -0.53
WillR(14)
Neutral -52.64
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
